PROFILE
UPM's Staff Profile
DR. MUHAMMAD HISHAR BIN HASSAN
PEGAWAI PENYELIDIK
CENTRE FOR DIAGNOSTIC NUCLEAR IMAGING
PROFESSIONAL
NAME :
(Dr.) Muhammad Hishar Bin Hassan
POSITION :
Pegawai Penyelidik
ENTITY :
Centre For Diagnostic Nuclear Imaging
DOWNLOAD CURRICULUM VITAE (PDF)
EDUCATIONAL BACKGROUND
2023
Doctor of Philosophy (Molecular Imaging), UPM
2019
IAEA Fellowship (Radiopharmaceutical Science), Westmead Hosp, NSW, Australia
2016
Master of Science (Molecular Imaging), UPM
2009
Professional Certificate (Radiation Protection Officer - Cyclotron Facility), AELB
2008
Professional Certificate (Unsealed Radioisotope Handling), UWA, Australia
2008
Preceptorship (Medical Cyclotron Management & PET Radiopharmaceuticals Production), SCGH, WA, Australia
2007
Bachelor of Science (Biotechnology), Monash University
CONSULTANCY SERVICES
2018
Editorial Board Member of Annals of Medicine & Medical Research
2017
Project Coordinator for IAEA TC Project
2015
Editorial Board Member of SM Radiology Journal
2014
Consultant, BV Logistics Sdn. Bhd.
2012
Radiation Protection Officer, BV Logistics Sdn. Bhd.
CONFERENCE / WORKSHOP / SEMINAR
2024
Aluminum Fluorination: Expanding the Role of Fluorine-18 in Biomolecule Labeling Strategies. Malaysia Nuclear Medicine Annual Conference 2024, Kuala Lumpur
2021
NOTA-Pamidronate kit: Novel Fluoride-18 (F-18)-based bone scanning agent. Pharm-IIDEx 2021, UiTM, Malaysia
2013
Investigation on the influence of waiting time period on the PET image quality. College of Radiology Annual Scientific Meeting 2013
PAPER PRESENTED
2024
A novel NOTAPAM radiolabeling with 68Ga. British Nuclear Medicine Society Annual Spring Meeting, Belfast, Ireland.
2024
Navigating radiolabeling challenges: Our experience with NOTA-pamidronic acid and [18F]AlF2+ complexes alongside 68Ga3+ ions. IPET 2024, Vienna, Austria
2023
Optimal radiolabeling conditions for [18F]AlF-NOTA-moiety. ISTR 2023, Vienna, Austria.
2023
[18F]AlF-complexation of pamidronic acid, a NOTA-conjugated bisphosphonate, as a potential tracer for PET bone imaging. European Association of Nuclear Medicine Congress 2023, Vienna, Austria.
2015
Optimizing the azeotropic drying of 18F- way to improve 18F-Fluorocholine radiochemical yields! European Association of Nuclear Medicine Congress 2015, Hamburg, Germany.
2015
Simplified and reliable quality control analysis method of 18F-Fluorocholine for a small scale hot lab. European Association of Nuclear Medicine Congress 2015, Hamburg, Germany.
2014
Patient dose management: Should we move to lean body mass? United Kingdom Radiological Congress 2014, Manchester, United Kingdom.
2013
Investigation on the influence of dose minimization management on the PET image quality. United Kingdom Radiological Congress 2013, Liverpool, United Kingdom.
2012
Association of total activity 18F-FDG injected with the overall PET image quality in oncology patients. National Conference on Physics 2012.
TEACHING
PET Radiopharmaceuticals in PET/CT Course organized by PPDN (2012 - present)
COMMITTEE
2023
Technical Member of Dasar Teknologi Nuklear Negara (DTNN) 2030
2022
World Council on Isotopes (WCI)
2021
Affiliate Member, Royal Society of Chemistry (RSC)
2015
Member of European Association of Nuclear Medicine
AWARD AND ACHIEVEMENT
2025
Travel Grant to ICARO-4, Vienna, Austria, 2 - 5 June 2025 (funded by IAEA, EUR 1,900)
2024
Travel Grant to IPET 2024, Vienna, Austria, 7 - 11 October 2024 (funded by IAEA, EUR 2120)
2021
Bronze Award, Pharm-IIDEx, Inspiring Innovation and Discovery
2019
Hadiah Latihan Persekutuan (HLP SLPP), KPM (2019 - 2022)
2019
Fellowship Program (funded by IAEA, EUR 4,060) to Westmead Hospital, Sydney, Australia, 4 Feb - 1 Mac 2019
2018
Anugerah Perkhidmatan Cemerlang 2017
2016
Scientific visit (funded by IAEA, USD 3,138) to All India Institute of Medical Sciences, New Delhi, India, 1 - 12 Februari 2016
2014
Scientific visit (funded by IAEA, USD 6,780) to San Raffaele Hospital, Milan & University of Milano-Bicocca, Milan, Italy, 15 - 26 September 2014
2013
Top 10 Scientific Poster at UKRC, Liverpool
2003
MARA Scholarship (Foundation Year & Undergraduate)
AREA OF SPECIALISATION
Cyclotron & radiopharmaceutical science
RESEARCH PROJECT
2023
University Putra Malaysia Grant (IPM), RM40,000 - Principal Investigator
2021
UiTM Collaboration Grant, RM20,000 - Co-Researcher
2017
University Putra Malaysia Grant (Putra Grant), RM40,000 - Principal Investigator
2014
Fundamental Research Grant Scheme (FRGS), RM110,000 - Co-Researcher
2013
University Putra Malaysia Grant (IPM), RM42,000 - Principal Investigator
2012
Research University Grant Scheme (RUGS), RM30,000 - Principal Investigator
2012
Research University Grant Scheme (RUGS), RM30,000 - Co-Researcher
PUBLICATION
2025
Hishar H, Omar Samri NF, Wan Kamal WHB, Othman MF. In Vivo biodistribution analysis of [68Ga]Ga-NOTA-pamidronic acid and [68Ga]Ga-DOTA-pamidronic Acid: Insights into bone-targeting radiopharmaceuticals. Journal of Radiation Research and Applied Sciences (accepted)
2024
Zarif Ashhar, Ahmad Fadzil MF, Hishar H, Othman MF, Md Hassan MB, Vincent Yong CV, Chan GC, Yusof NA. 2024. The potential of radiolabeled bisphosphonates in SPECT and PET for bone imaging. Current Medical Imaging;20(1)
2024
Hishar, H., Othman, MF., Ashhar, ZN., Abdul Razak, HR., Ahmad Saad, FF. 2024. Unveiling the potential of Prostate-Specific Membrane Antigen (PSMA) for precision diagnosis and therapy of prostate cancer: A radiopharmaceutical perspective. Malaysian Journal of Medical Sciences, 31;4:213-217
2024
Naza Badi, IH., Hishar, H., Wan Kamal, WHB., Abdul Razak, HR., Othman, MF. 2024. A novel NOTAPAM radiolabeling with 68Ga. Nuclear Medicine Communication, 45:5:426
2023
Hishar H, Othman MF, Abdul Razak HR, Zakaria ZA, Fathinul Fikri AS. [18F]AlF-complexation of pamidronic acid, a NOTA-conjugated bisphosphonate, as a potential tracer for PET bone imaging. European Journal of Nuclear Medicine & Molecular Imaging; 50(S1):209
2022
Hishar H, Othman MF, Abdul Razak HR, Zakaria ZA, Fathinul Fikri AS, Osman MA, Loh HY, Ashhar Z, Idris J, Abdul Hamid MHN, Md Safee Z. Preparation, optimisation and in vitro evaluation of [18F]AlF-NOTA-Pamidronic acid for bone imaging PET. Molecules, 27(22), 7969
2021
Hishar, H., Othman, MF., Zakaria, ZA., Fathinul Fikri, AS., Abdul Razak, HR. 2021. Analytical GC-FID method for the determination of organic solvents in radiopharmaceutical. Current Radiopharmaceuticals, 14(2):131-144
2021
Hishar, H., Othman, MF., Zakaria, ZA., Fathinul Fikri, AS., Abdul Razak, HR. 2021. Assessing the influence of neglected GC-FID variables on the multiple responses using multivariate optimization for the determination of ethanol and acetonitrile in radiopharmaceuticals. SN Applied Sciences, 3:251
2021
Hishar, H., Othman, MF. & Abdul Razak, HR. 2021. [18F]-labeled bisphosphonate as an alternative candidate to the gold standard [18F]-sodium fluoride ([18F]NaF) for PET bone imaging. Current Medical Imaging, 17(11):1271-1275
2021
Hishar, H., Othman, MF. & Abdul Razak, HR. 2021. Optimal [18F]-fluorination conditions for the high radiochemical yield of [18F]AlF-NOTA-NHS complexes. Radiochimica Acta (Accepted)